A Multifactorial Weight Reduction Programme for Children with Overweight and Asthma: A Randomized Controlled Trial

There is increasing evidence that obesity is related to asthma development and severity. However, it is largely unknown whether weight reduction can influence asthma management, especially in children. To determine the effects of a multifactorial weight reduction intervention on asthma management in...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 11; no. 6; p. e0157158
Main Authors Willeboordse, Maartje, van de Kant, Kim D G, Tan, Frans E S, Mulkens, Sandra, Schellings, Julia, Crijns, Yvonne, Ploeg, Liesbeth van der, van Schayck, Constant P, Dompeling, Edward
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 13.06.2016
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:There is increasing evidence that obesity is related to asthma development and severity. However, it is largely unknown whether weight reduction can influence asthma management, especially in children. To determine the effects of a multifactorial weight reduction intervention on asthma management in overweight/obese children with (a high risk of developing) asthma. An 18-month weight-reduction randomized controlled trial was conducted in 87 children with overweight/obesity and asthma. Every six months, measurements of anthropometry, lung function, lifestyle parameters and inflammatory markers were assessed. Analyses were performed with linear mixed models for longitudinal analyses. After 18 months, the body mass index-standard deviation score decreased by -0.14±0.29 points (p<0.01) in the intervention group and -0.12±0.34 points (p<0.01) in the control group. This change over time did not differ between groups (p>0.05). Asthma features (including asthma control and asthma-related quality of life) and lung function indices (static and dynamic) improved significantly over time in both groups. The FVC% predicted improved over time by 10.1 ± 8.7% in the intervention group (p<0.001), which was significantly greater than the 6.1 ± 8.4% in the control group (p<0.05). Clinically relevant improvements in body weight, lung function and asthma features were found in both the intervention and control group, although some effects were more pronounced in the intervention group (FVC, asthma control, and quality of life). This implies that a weight reduction intervention could be clinically beneficial for children with asthma. ClinicalTrials.gov NCT00998413.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-3
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
Competing Interests: The authors received funding from TEVA Pharmaceuticals BV, a commercial company, in the form of unrestricted grants. There are no patents, products in development, or marketed products to declare. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Conceived and designed the experiments: ED CS KK MW. Performed the experiments: MW KK LP JS YC. Analyzed the data: MW FT ED CS. Contributed reagents/materials/analysis tools: SM JS YC LP. Wrote the paper: MW FT ED CS KK.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0157158